Open AccessUp-down determination of the 90% effective dose (ED90) of remimazolam besylate for anesthesia induction
Author(s) -
Zhi-xia LU,
N. Zhou,
Yan Li,
Li Yang,
Wei Hao
Publication year - 2022
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-22-89
Subject(s) - medicine , sedation , colonoscopy , anesthesia , benzodiazepine , adverse effect , pharmacology , colorectal cancer , receptor , cancer
Remimazolam besylate for injection is a novel benzodiazepine. Reasonable selection and proper application of anesthetics is critical for patients. This study aims to determine the 90% effective dose (ED90) of remimazolam besylate for anesthesia induction in patients undergoing painless colonoscopy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom